Moreover, gene knockdown experiments revealed that Blk promoted the proliferation of malignant T cells in CTCL patients [30] while another study suggested that murine Blk also has tumor-suppressive functions depending on the specific cellular context [29]. This evidence concerns the gene BLK and primary cutaneous T-cell non-Hodgkin lymphoma.